MX2023008876A - Tratamiento de la apnea del sueño con cannabidiol (cbd). - Google Patents

Tratamiento de la apnea del sueño con cannabidiol (cbd).

Info

Publication number
MX2023008876A
MX2023008876A MX2023008876A MX2023008876A MX2023008876A MX 2023008876 A MX2023008876 A MX 2023008876A MX 2023008876 A MX2023008876 A MX 2023008876A MX 2023008876 A MX2023008876 A MX 2023008876A MX 2023008876 A MX2023008876 A MX 2023008876A
Authority
MX
Mexico
Prior art keywords
cbd
treatment
sleep apnea
cannabidiol
patients
Prior art date
Application number
MX2023008876A
Other languages
English (en)
Spanish (es)
Inventor
Donna Gutterman
Terri Sebree
Joseph Palumbo
Original Assignee
Zynerba Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zynerba Pharmaceuticals Inc filed Critical Zynerba Pharmaceuticals Inc
Publication of MX2023008876A publication Critical patent/MX2023008876A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M21/00—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physics & Mathematics (AREA)
  • Acoustics & Sound (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Glass Compositions (AREA)
MX2023008876A 2021-01-28 2022-01-28 Tratamiento de la apnea del sueño con cannabidiol (cbd). MX2023008876A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202163142835P 2021-01-28 2021-01-28
PCT/IB2022/050781 WO2022162621A1 (en) 2021-01-28 2022-01-28 Treatment of sleep apnea with cbd

Publications (1)

Publication Number Publication Date
MX2023008876A true MX2023008876A (es) 2023-09-12

Family

ID=80222209

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2023008876A MX2023008876A (es) 2021-01-28 2022-01-28 Tratamiento de la apnea del sueño con cannabidiol (cbd).

Country Status (11)

Country Link
US (1) US20240307418A1 (cg-RX-API-DMAC7.html)
EP (1) EP4284349A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024505212A (cg-RX-API-DMAC7.html)
KR (1) KR20230137404A (cg-RX-API-DMAC7.html)
CN (1) CN116829135A (cg-RX-API-DMAC7.html)
AU (1) AU2022213009A1 (cg-RX-API-DMAC7.html)
CA (1) CA3206508A1 (cg-RX-API-DMAC7.html)
IL (1) IL304827A (cg-RX-API-DMAC7.html)
JO (1) JOP20230169A1 (cg-RX-API-DMAC7.html)
MX (1) MX2023008876A (cg-RX-API-DMAC7.html)
WO (1) WO2022162621A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20260207632A1 (en) * 2022-12-16 2026-07-23 Kingdom Therapeutics Limited Cannabinoid based therapy

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8449908B2 (en) 2000-12-22 2013-05-28 Alltranz, Llc Transdermal delivery of cannabidiol
WO2010127033A1 (en) 2009-04-28 2010-11-04 Alltranz Inc. Formulations of cannabidiol and methods of using the same
CA3065563C (en) * 2017-06-19 2023-06-13 Zelda Therapeutics Operations Pty Ltd Sleep disorder compositions and treatments thereof
GB2572737A (en) * 2018-01-24 2019-10-16 Gw Res Ltd Use of cannabinoids in the treatment of epilepsy
CA3099980A1 (en) * 2018-05-11 2019-11-14 Rhodes Technologies Inc. Compositions and dosage forms for oral delivery
WO2019224824A1 (en) * 2018-05-24 2019-11-28 To Pharmaceuticals Llc Cannabis-based compositions for the treatment of autistic spectrum disorders
EP3753555A1 (en) * 2019-06-19 2020-12-23 Universität Basel Composition for inhalation comprising cannabidiol for the treatment of mental disorder and/or drug addiction and/or sleep disorder and/or pain
WO2021055499A1 (en) * 2019-09-17 2021-03-25 Zynerba Pharmaceuticals, Inc. Treatment of behavioral impairment in developmental and epileptic encephalopathy

Also Published As

Publication number Publication date
CN116829135A (zh) 2023-09-29
US20240307418A1 (en) 2024-09-19
IL304827A (en) 2023-09-01
WO2022162621A1 (en) 2022-08-04
JP2024505212A (ja) 2024-02-05
AU2022213009A1 (en) 2023-08-17
EP4284349A1 (en) 2023-12-06
KR20230137404A (ko) 2023-10-04
JOP20230169A1 (ar) 2023-07-27
CA3206508A1 (en) 2022-08-04

Similar Documents

Publication Publication Date Title
JOP20200031A1 (ar) طرق لعلاج الالتهاب العظمي المفصلي باستخدام هلام من كانابيديول عبر الأدمة
MX2014004548A (es) Metodos para tratar pacientes pediatricos usando dexmedetomidina.
MX2022003193A (es) Tratamiento de encefalopatia asociada al gen syngap1.
EA201491460A1 (ru) ПРИМЕНЕНИЕ ЛАХИНИМОДА В ЛЕЧЕНИИ ПАЦИЕНТОВ С БОЛЕЗНЬЮ КРОНА, У КОТОРЫХ НЕ ЭФФЕКТИВНА ТЕРАПИЯ ПЕРВОЙ ЛИНИИ АНТИ-TNFα
MX2023005455A (es) Metodos de tratamiento de la insuficiencia cardiaca mediante la administracion de omecamtiv mecarbil.
NZ630367A (en) Methods of treatment of pediatric solid tumor
MX2024011142A (es) Tratamiento de neurofibromas cutaneos con mirdametinib.
MX2023006551A (es) Tratamiento de las convulsiones refractarias.
EP4623999A3 (en) Sotorasib for use in the treatment of cancer
JOP20230169A1 (ar) علاج انقطاع النفس أثناء النوم باستخدام cbd
MX2023003258A (es) Tratamiento de enfermedades mediadas por nf-kb.
MX2023009024A (es) Combinaciones terapeuticas de rosuvastatina y resmetirom para el tratamiento de trastornos hepaticos o trastornos lipidicos.
BR112023023702A2 (pt) Métodos de tratamento da cistite intersticial/síndrome da dor na bexiga
PH12022553441A1 (en) Compositions and methods for treating obsessive-compulsive disorder
MX2026000090A (es) Lemborexant para el tratamiento de problemas del sueño
EA032959B9 (ru) Применение бремеланотида в терапии женской сексуальной дисфункции
MX2023006765A (es) Metodo para proporcionar terapia de celiprolol a un paciente.
RU2009115409A (ru) Способ восстановительного лечения пациентов, перенесших холецистэктомию
MX2025000385A (es) Metabolitos de belumosudil y usos de los mismos en el tratamiento de la enfermedad cronica del injerto contra el hospedero
UA87836U (ru) Способ лечения болезни гоше у больных различных возрастных групп
MX2024008256A (es) Metodos de tratamiento de la enfermedad por coronavirus y compuestos para el mismo.
UA95166U (uk) Спосіб лікування гострої невропатії лицевого нерва у дітей
NZ788497A (en) Use of reboxetine to treat nervous system disorders
Lu et al. Chinese medicinal herb therapy for the rehabilitation of peripheral facial palsy
Wu Treatment of 28 cases of hiccup following cerebral infarction by acupuncture